Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JAC/DKL274PMID 16895941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

  2004cited by this paper
• Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.

  2003cited by this paper
• Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

  2003cited by this paper
• Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii

  2002cited by this paper
• Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window.

  2002cited by this paper
• Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of MultiresistantAcinetobacter baumannii

  2000cited by this paper
• In Vivo Efficacies of Combinations of β-Lactams, β-Lactamase Inhibitors, and Rifampin against Acinetobacter baumannii in a Mouse Pneumonia Model

  1999cited by this paper
• In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model.

  1999cited by this paper
• The use of antibiotics : a clinical review of antibacterial, antifungal, and antiviral drugs

  1997cited by this paper
• Definition and determination of in vitro antibiotic susceptibility breakpoints for Bacteria in France

  1994cited by this paper
• Diagnostic molecular microbiology : principles and applications

  1993cited by this paper
• Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology.

  1990cited by this paper
• THE USE OF ANTIBIOTICS

  1952cited by this paper

• Development of a new Acinetobacter baumannii pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies

  2024cites this paper
• Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective

  2022cites this paper
• Use of colistin with rifampicin, trimethoprim-sulfamethoxazole and teicoplanin in acinetobacter mouse infection model.

  2022cites this paper
• The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy

  2021cites this paper
• Colistin: Mechanisms of antibiotic resistance and logical approach to its use

  2021cites this paper
• Multidrug-resistant : mechanisms of virulence and resistance

  2020cites this paper
• In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug Resistant Acinetobacter baumannii

  2020cites this paper
• In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

  2019cites this paper
• A Case Report of Persistent Acinetobacter baumannii Bloodstream Infection

  2019cites this paper
• Molecular mechanisms related to colistin resistance in Enterobacteriaceae

  2019cites this paper
• Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review

  2019cites this paper
• In Vitro Susceptibility Testing of Rifampin against Acinetobacter Baumannii: Comparison of Disc Diffusion, Agar Dilution, and Etest

  2019cites this paper
• Busscher the Surface Biomaterial-Associated Infection : Locating the Finish Line in the Race for

  2018cites this paper
• Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii

  2018cites this paper
• Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia – A case report

  2018cites this paper
• Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients

  2018cites this paper
• Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell

  2017cites this paper
• Screening of mutator phenotype in clinical strains of Acinetobacter baumannii.

  2017cites this paper
• Role of rifampin for the treatment of bacterial infections other than mycobacteriosis.

  2017cites this paper
• A Cross Sectional Study Characerization and Antimicrobial Susceptibility Pattern of Clinical Isolates of Acinetobacter at a Tertiary Health Care Teaching Hospital, Bhavnagar, Gujarat

  2017cites this paper
• Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections

  2017cites this paper
• Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India.

  2016cites this paper
• Epidemiology and Cytokine Levels among Children with Nosocomial Multidrug-Resistant Acinetobacter baumannii Complex in a Tertiary Hospital of Eastern China

  2016cites this paper
• The role of the AdeRS two component system and the AdeABC RND efflux pump in antibiotic resistance, biofilm formation and virulence in Acinetobacter baumannii

  2016cites this paper
• Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria.

  2016cites this paper
• Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii

  2016cites this paper
• Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.

  2016cites this paper
• Effects of Colistin Sulphate, Tigecycline, and Cefoperazone-Sulbactam on the Multi-Drug Resistant Acinetobacter baumannii Experimental Mouse Sepsis Model

  2015cites this paper
• Task force on management and prevention of Acinetobacter baumannii infections in the ICU

  2015cites this paper
• Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review

  2015cites this paper
• Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia

  2015cites this paper
• In vitro activity of rifampicin alone and in combination with imipenem against multidrug-resistant Acinetobacter baumannii harboring the blaOXA-72 resistance gene

  2014cites this paper
• Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections

  2014influential citation
• Antimicrobial susceptibility of Acinetobacter baumannii isolated from hospital patients

  2014cites this paper
• In vitro activity of imipenem combination with colistin or rifampicin against clinical isolates of Acinetobacter baumannii and his antimicrobial susceptibility profil

  2014cites this paper
• Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.

  2014cites this paper
• Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic Management.

  2013cites this paper
• Combination therapy for Gram-negative bacteria: what is the evidence?

  2013cites this paper
• Adaptation and development of a new method for measuring antibiotic and dye accumulation in Acinetobacter baumannii

  2013cites this paper
• Strategies of empiric antibiotic therapy in severe sepsis.

  2012cites this paper
• Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy.

  2012cites this paper
• Therapeutic options for Acinetobacter baumannii infections: an update

  2012cites this paper
• Rifampin breakpoint for Acinetobacter baumannii based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.

  2012cites this paper
• Biomaterial-Associated Infection: Locating the Finish Line in the Race for the Surface

  2012cites this paper
• Treatment Options for Multidrug-Resistant Acinetobacter Species

  2012cites this paper
• In vitro activity of antibiotic combinations against multidrug-resistant strains of Acinetobacter baumannii and the effects of their antibiotic resistance determinants.

  2012cites this paper
• In vitro synergistic activity of carbapenems in combination with other antimicrobial agents against multidrug-resistant Acinetobacter baumannii

  2012cites this paper
• Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.

  2011influential citation
• In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase

  2011cites this paper
• Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?

  2011cites this paper
• Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains

  2011cites this paper
• Pharmacodynamic assessment of vancomycin–rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis

  2011cites this paper
• Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.

  2011cites this paper
• Efficacy of rifampin and its combinations with imipenem , sulbactam , and colistin 1 in experimental models caused by imipenem-resistant Acinetobacter baumannii . 2 3

  2010cites this paper
• Multidrug Resistant Acinetobacter

  2010cites this paper
• Multiresistant Acinetobacter baumannii infections: epidemiology and management

  2010cites this paper
• Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis

  2010cites this paper
• Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model.

  2010cites this paper
• [Multidrug resistant Acinetobacter baumanii:clinical update and new highlights].

  2010cites this paper
• Rifampicin combined regimens for gram-negative infections: data from the literature.

  2010cites this paper
• Treatment options for multidrug-resistant nonfermenters

  2010cites this paper
• Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

  2010cites this paper
• Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.

  2010cites this paper
• A rapid and simple method for constructing stable mutants of Acinetobacter baumannii

  2010influential citation
• Acinetobacter baumanii multirresistente: situación clínica actual y nuevas perspectivas

  2010cites this paper
• DEMONSTRATION OF PHARMACOMETRIC APPLICATIONS TO ANTI-INFECTIVE CHEMOTHERAPY

  2010cites this paper
• Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

  2010cites this paper
• Rifampin Combination Therapy for Nonmycobacterial Infections

  2010cites this paper
• In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii

  2010cites this paper
• Treatment of multiresistant Acinetobacter baumannii infections.

  2009cites this paper
• Rifampin resistance in carbapenem-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.

  2009cites this paper
• In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore

  2009cites this paper
• Management of meningitis due to antibiotic-resistant Acinetobacter species.

  2009cites this paper
• Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.

  2009cites this paper
• Antimicrobial Resistance and Therapeutic Alternatives

  2008cites this paper
• Effects of Aerosol Colistin Treatment of Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii

  2008cites this paper
• Drug treatment for multidrug-resistant Acinetobacter baumannii infections.

  2008cites this paper
• Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii

  2008cites this paper
• Current Concepts Acinetobacter Infection

  2008cites this paper
• Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.

  2008cites this paper
• Therapeutic options for Acinetobacter baumannii infections

  2008cites this paper
• Acinetobacter infection.

  2008cites this paper
• Acinetobacter infection in the ICU.

  2008cites this paper
• Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.

  2008cites this paper
• Acinetobacter baumannii: Emergence of a Successful Pathogen

  2008cites this paper
• Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

  2008cites this paper
• Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.

  2008cites this paper
• Formulation of rifampicin-cyclodextrin complexes for lung nebulization.

  2008cites this paper
• Optimizing Therapy for Acinetobacter baumannii

  2007cites this paper
• Global Challenge of Multidrug-Resistant Acinetobacter baumannii

  2007cites this paper
• Non-fermentative Gram-negative bacteria.

  2007cites this paper
• Optimizing therapy for Acinetobacter baumannii.

  2007cites this paper
• An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

  2007cites this paper
• Study of the antifungal activity of Acinetobacter baumannii LCH001 in vitro and identification of its antifungal components

  2007cites this paper
• Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management

  2007cites this paper
• The Global Challenge of Multidrug Resistant (MDR)

  2007cites this paper
• Acinetobacter pneumonia: a review.

  2007cites this paper
• In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.

  2007cites this paper
• Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2.

  2007cites this paper
• Management of ventilator-associated pneumonia caused by multiresistant bacteria

  2007cites this paper